Bausch + Lomb Q2 FY26 GAAP net loss narrows to $14 million; revenue rises 9% to $1.39 billion

• Second-quarter revenue rose 9% to $1.39 billion.
• Net loss attributable to shareholders narrowed to $14 million from $62 million; GAAP EPS improved to a loss of $0.04.
• Operating income swung to $83 million from an operating loss of $11 million; adjusted EBITDA (non-GAAP) climbed to $241 million from $191 million.
• Segment revenue rose 4% to $784 million in Vision Care, 19% to $256 million in Surgical, 15% to $354 million in Pharmaceuticals.
• Raised 2026 revenue outlook to $5.44 billion-$5.54 billion; lifted adjusted EBITDA excluding acquired IPR&D (non-GAAP) to $1.03 billion-$1.08 billion.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bausch + Lomb Corp. published the original content used to generate this news brief via Business Wire (Ref. ID: 202607290658BIZWIRE_USPR_____20260729_BW411548) on July 29, 2026, and is solely responsible for the information contained therein.